CYP7A1 and metabolic dysfunction-associated steatotic liver disease: Decreased expression of Cholesterol 7 alpha-hydroxylase (CYP7A1) has been reported in NAFLD patients, resulting in decreased synthesis of bile acids from cholesterol [105].